THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT?

THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT?

Aim. To study the opinion of doctors about the possibility of statins prescription to patients with cardiovascular diseases and concomitant chronic liver diseases.Material and methods. Сross-sectional questioning of the random sample of physicians was performed. Results. 70 physicians (internists -...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	statins liver diseases the safety of therapy high risk of cardiovascular disease dyslipidemia
Online Access:	https://www.rpcardio.online/jour/article/view/124
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA?
by: S. N. Bel'diev
Published: (2016-06-01)

SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION
by: S. N. Bel'diev
Published: (2017-03-01)

THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY)
by: N. P. Kutishenko, et al.
Published: (2015-09-01)

STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

STATINS AND RISK OF INFECTIOUS DISEASES
by: O. M. Drapkina, et al.
Published: (2015-09-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS
by: A. О. Shevchenko
Published: (2016-06-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Cardiovascular risk management beyond statins: review of new therapies available in Italy
by: Maurizio Capuozzo, et al.
Published: (2025-07-01)

Statin therapy in patients with high and very high cardiovascular risk: an optimal approach
by: E. V. Sayutina, et al.
Published: (2020-11-01)

Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice
by: D. V. Nebieridze, et al.
Published: (2020-09-01)

COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE
by: S. V. Shalaev, et al.
Published: (2016-01-01)

GENERICS STATINS: ARE ALL SO EASY WITH EVIDENCE OF CLINICAL EQUIVALENCE?
by: S. Yu. Martsevich, et al.
Published: (2015-10-01)

STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE
by: L. N. Malay
Published: (2015-09-01)

Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits
by: S. A. Davitashvili, et al.
Published: (2021-03-01)

TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE
by: V. A. Korneva, et al.
Published: (2015-09-01)

A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol
by: K. P. Raevskii, et al.
Published: (2025-06-01)

MICROCIRCULATORY ISCHEMIA AND STATINS: LESSONS OF INTERVENTION CARDIOLOGY
by: An. A. Alexandrov, et al.
Published: (2015-12-01)

ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I
by: N. M. Akhmedzhanov, et al.
Published: (2015-09-01)

Joint associations of pre-diabetes, pre-hypertension, and pre-dyslipidemia with cardiovascular and metabolic disease progression
by: Cui Ma, et al.
Published: (2025-08-01)

Sex differences in guideline-based statin utilization and recurrent events in patients with known coronary artery disease
by: Agnes Koczo, et al.
Published: (2025-09-01)

STATIN SAFETY REVISITED DATA
by: O. M. Drapkina
Published: (2015-09-01)

RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
by: D. A. Anichkov, et al.
Published: (2015-12-01)

PROBLEM OF TREATMENT WITH STATINS IN RUSSIA: WILL GENERICS HELP?
by: S. Y. Martsevich
Published: (2016-01-01)

STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY
by: Y. A. Karpov
Published: (2015-12-01)

Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data)
by: S. Yu. Martsevich, et al.
Published: (2022-03-01)

MODERN PRINCIPLES OF QUALITY ASSESSMENT OF CARDIOVASCULAR DISEASES TREATMENT
by: A. Yu. Suvorov, et al.
Published: (2015-09-01)

Pharmacogenetics of HMG-CoA reductase inhibitors (statins): perspectives of individualized, genotype-based therapy
by: D. A. Sychev, et al.
Published: (2006-02-01)

A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases
by: Yu. V. Bulaeva, et al.
Published: (2021-11-01)

STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY?
by: I. N. Grigorieva, et al.
Published: (2016-01-01)

STATIN GENERICS: EFFICACY AND SAFETY RATIO
by: V. P. Voronina, et al.
Published: (2016-01-01)

Interdisciplinary Expert Consensus: the place of original pitavastatin in primary and secondary prevention of cardiovascular diseases
by: M. G. Bubnova, et al.
Published: (2024-12-01)

We act as early as possible and prescribe for as long as possible! Individualised approach to statin therapy
by: M. V. Chirkova
Published: (2024-11-01)

Statins and their impact on epigenetic regulation: insights into disease
by: Rafael Tamayo-Trujillo, et al.
Published: (2025-07-01)

New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors
by: V. V. Syvolap, et al.
Published: (2014-04-01)

The relationship between dyslipidemia and chronic liver disease, with the mediating role of depressive symptoms
by: Wencheng Li, et al.
Published: (2025-08-01)

The Pathogenetic Basis of the Action of Bempedoic Acid
by: A. S. Petrosyan, et al.
Published: (2023-01-01)

ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT?
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study)
by: S. Yu. Martsevich, et al.
Published: (2019-01-01)

STATINS AND THE RISK OF DIABETES MELLITUS
by: O. M. Drapkina
Published: (2015-09-01)